Skip to main content
Clinical Trials/NCT05212558
NCT05212558
Completed
N/A

The Rationale of Applying Inspiratory/Expiratory Muscle Training Within the Same Respiratory Cycle in Children With Bronchial Asthma: A Placebo-controlled Randomized Clinical Trial

Cairo University1 site in 1 country51 target enrollmentAugust 2, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bronchial Asthma
Sponsor
Cairo University
Enrollment
51
Locations
1
Primary Endpoint
Inspiratory muscle strength
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study was designed to assess the effect of inspiratory and expiratory muscle training in the same cycle on respiratory muscle strength, pulmonary functions, perception of asthma symptoms in children with bronchial asthma. Fifty-one children with bronchial asthma were randomly allocated to the unloaded respiratory muscle training (Placebo training group; n = 17), inspiratory muscle training alone (inspiratory muscle training group; n = 17), or combined inspiratory and expiratory muscle training in the same cycle (combined training group; n = 17). All groups were assessed for respiratory muscle strength, pulmonary functions, and asthma symptoms.

Detailed Description

Fifty-one children with bronchial asthma were recruited from King Khalid Hospital, Al-Kharj, Saudi Arabia. The study included children who had a confirmed diagnosis of bronchial asthma according to the Global Initiative for Asthma guidelines, aged 12-18 years, identified as being stable cases, had a baseline percent-predicted value of the peak expiratory flow rate of 60-80%, sustained stale doses of medications in the past three months. Children who had unstable asthma or exacerbated asthma symptoms, history of thoracic surgery, or cardiopulmonary comorbidities were excluded. Outcome measures 1. Respiratory muscle strength: assessed by measuring the maximal inspiratory and expiratory pressure using an electronic respiratory pressure meter. 2. Pulmonary function: The forced vital capacity (FVC), forced expiratory volume in the first second of expiration (FEV1), and FEV1/FVC ratio, were measured in a pulmonary function test through a spirometry analyzer. 3. Control of asthma symptoms: Asthma symptoms were assessed using a translated version of the asthma control test. All groups received the conventional respiratory re-training program, three times a week, for 12 weeks in succession. The placebo group additionally received unloaded respiratory muscle training, the inspiratory muscle training group received respiratory muscle training alone, and the combined group received combined inspiratory and expiratory muscle training in the same cycle. Interventions were conducted by a licensed physical therapist who had experience of more than 10 years of respiratory training.

Registry
clinicaltrials.gov
Start Date
August 2, 2020
End Date
October 28, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ragab Kamal Elnaggar

Associate Professor

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnosis of asthma according to Global Initiative of Asthma guidelines.
  • Age between 12 and 18 years.
  • Clinically stable asthma.
  • Stable doses of medications in the last three months
  • A percent-predicted value of the peak expiratory flow rate of 60-80%
  • No activity limitation due to asthma

Exclusion Criteria

  • Unstable asthma
  • Exacerbation of asthma symptoms
  • History of thoracic surgery
  • Cognitive/behavioral problems
  • Cardiopulmonary co-morbidities

Outcomes

Primary Outcomes

Inspiratory muscle strength

Time Frame: 2 months

Inspiratory muscle strength was assessed by measuring the maximal inspiratory pressure (reflects the strength of the diaphragm and other inspiratory muscles) using an electronic respiratory pressure meter, according to the American Thoracic Society and European Respiratory Society standards. The highest value of three acceptable trials was documented and used for the subsequent analysis. The percent predicted maximal inspiratory pressure values (%) were calculated and used for statistical analysis.

Expiratory muscle strength

Time Frame: 2 months

Expiratory muscle strength was assessed by measuring the maximal expiratory pressure (reflects the strength of the abdominal muscles and other expiratory muscles) using an electronic respiratory pressure meter, according to the American Thoracic Society and European Respiratory Society standards. The highest value of three acceptable trials was documented and used for the subsequent analysis. The percent predicted maximal inspiratory pressure values (%) were calculated and used for statistical analysis.

Forced vital capacity

Time Frame: 2 months

Forced vital capacity, which is the amount of air that each participant was able to forcibly exhale from his/her lungs after taking the deepest breath they can, was measured in a pulmonary function test with a spirometry analyzer and expressed as a percentage of predicted values (%). Three trials were allowed and the best results were recorded.

Forced expiratory volume in one second

Time Frame: 2 months

Forced expiratory volume in one second, which is the volume of air exhaled in the first second during forced exhalation after a maximal inspiration, was measured in a pulmonary function test with a spirometry analyzer and expressed as a percentage of predicted values (%). Three trials were allowed and the best results were recorded.

Forced expiratory volume in one second / forced vital capacity

Time Frame: 2 months

Forced expiratory volume in one second / forced vital capacity, is the ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs.

Secondary Outcomes

  • Asthma symptoms(2 months)

Study Sites (1)

Loading locations...

Similar Trials